Purchase Order SPE2DP25P0353
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $1,014.52 contract is for the delivery of diluting solution, an essential medical supply used in various healthcare and biomedical research applications. The award does not have a set-aside designation, indicating Fenwal's competitive capabilities in the federal procurement...
- This federal contract award to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, is a $1,139.76 firm fixed-price purchase order for the supply of a "DILUTING SOLUTION,F" medical product. The contract was awarded on April 29, 2025, with an ultimate completion date of May 20, 2025. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to support critical healthcare programs, including military medical supply chains, biomedical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The $1,139.76 contract is for the supply of a diluting solution (CLIN 8511335096) with a period of performance ending on June 30, 2025. Fenwal, Inc. is a registered federal vendor that has consistently secured contract awards from various U.S. government agencies, including the DLA, National...
- This federal contract award, valued at $1,014.52, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a DILUTING SOLUTION,F product, which is likely a specialized medical supply or consumable used in healthcare or biomedical research applications. The contract is a firm fixed-price purchase order with no set-aside designation, indicating Fenwal's competitive capabilities in the...
- This federal contract award is for the procurement of a DILUTING SOLUTION,F product by the U.S. government. The contract was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract has a firm fixed price of $1,519.68 and an ultimate completion date of May 20, 2025. It was awarded by the Defense Logistics Agency (DLA), which supports the defense and civilian medical supply chains. Fenwal, Inc. is a registered...
- This federal contract award, valued at $3,297.19, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a Diluting Solution, which is a specialized medical supply that supports healthcare and biomedical research initiatives. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Fenwal's competitive capabilities in the federal procurement...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- The U.S. Defense Logistics Agency awarded a $2,188.92 firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of "Washing Solution, FR" to support the agency's medical supply chain operations. This award does not have a set-aside designation. Fenwal has extensive experience providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, and specialized items,...
- This firm fixed-price purchase order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,188.92 contract is for the supply of washing solution, FR (flame retardant) to support federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. Fenwal has a long history of providing a wide range of medical supplies and...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of "WASHING SOLUTION,FR" and has a ceiling value of $5,135.32 with a period of performance through September 8, 2025. The contract was awarded on July 8, 2025 and does not have a set-aside designation. Fenwal, Inc. is a registered vendor with...
The U.S. Department of Defense's Medical Supply Chain awarded a $4,938.96 firm fixed-price purchase order to Fenwal, Inc. on July 8, 2025, for the supply of diluting solution. The contract, which carries an ultimate completion date of September 8, 2025, was awarded without a set-aside designation, reflecting Fenwal's competitive standing in federal procurement. Performance will take place at Fenwal's facility in Lake Zurich, Illinois, where the company manufactures specialized blood technology products and medical consumables. Fenwal, Inc., a subsidiary of Fresenius Kabi and a long-standing federal vendor since 2007, specializes in blood collection, separation, storage, and transfusion products that support military medical supply chains and healthcare initiatives. This purchase order for diluting solution aligns with the company's established role as a critical supplier of blood banking consumables and processing solutions to the Defense Logistics Agency, Defense Health Agency, and other federal healthcare entities. The contract represents a routine replenishment of essential medical supplies required to maintain blood banking operations across the Department of Defense's medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/8/25 |